Phase 2 Sjogren's Syndrome trials recruiting now

All Sjogren's Syndrome trials, every phase

Other phases for Sjogren's Syndrome

Phase 2 Sjogren's Syndrome trials

• Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
  NCT07062523 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
  NCT06350110 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
  NCT07281456 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
  NCT06428188 · Phase: Phase 1, Phase 2 · Ages: 21 Years to 90 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.